The association between bacteria and outcome and the influence of sampling method, in people with a diabetic foot infection.
Amputation
Bacteria
Diabetes mellitus
Diabetic foot infection
Mortality
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
19
05
2022
accepted:
28
06
2022
medline:
29
3
2023
pubmed:
23
7
2022
entrez:
22
7
2022
Statut:
ppublish
Résumé
Different bacteria lead to divers diabetic foot infections (DFIs), and some bacteria probably lead to higher amputation and mortality risks. We assessed mortality and amputation risk in relation to bacterial profiles in people DFI and investigated the role of sampling method. We included people (> 18 years) with DFI in this retrospective study (2011-2020) at a Dutch tertiary care hospital. We retrieved cultures according to best sampling method: (1) bone biopsy; (2) ulcer bed biopsy; and (3) swab. We aggregated data into a composite determinant, consisting of unrepeated bacteria of one episode of infection, clustered into 5 profiles: (1) Streptococcus and Staphylococcus aureus; (2) coagulase-negative Staphylococcus, Cutibacterium, Corynebacterium and Enterococcus; (3) gram-negative; (4) Anaerobic; and (5) less common gram-positive bacteria. We calculated Hazard Ratio's (HR's) using time-dependent-Cox regression for the analyses and investigated effect modification by sampling method. We included 139 people, with 447 person-years follow-up and 459 episodes of infection. Sampling method modified the association between bacterial profiles and amputation for profile 2. HR's (95% CI's) for amputation for bacterial profiles 1-5: 0.7 (0.39-1.1); stratified analysis for profile 2: bone biopsy 0.84 (0.26-2.7), ulcer bed biopsy 0.89 (0.34-2.3), swab 5.9*(2.9-11.8); 1.3 (0.78-2.1); 1.6 (0.91-2.6); 1.6 (0.58-4.5). HR's (95% CI's) for mortality for bacterial profiles 1-5: 0.89 (0.49-1.6); 0.73 (0.38-1.4); 2.6*(1.4-4.8); 1.1(0.58-2.2); 0.80(0.19-3.3). In people with DFI, there was no association between bacterial profiles in ulcer bed and bone biopsies and amputation. Only in swab cultures, low-pathogenic bacteria (profile 2), were associated with a higher amputation risk. Infection with gram-negative bacteria was associated with a higher mortality risk. This study underlined the possible negative outcome of DFI treatment based on swabs cultures.
Identifiants
pubmed: 35869352
doi: 10.1007/s15010-022-01884-x
pii: 10.1007/s15010-022-01884-x
pmc: PMC10042898
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
347-354Informations de copyright
© 2022. The Author(s).
Références
Eur J Intern Med. 2003 Aug;14(5):341-343
pubmed: 13678763
N Engl J Med. 2017 Jun 15;376(24):2367-2375
pubmed: 28614678
Open Forum Infect Dis. 2017 Feb 11;4(1):ofx016
pubmed: 28480287
BMC Infect Dis. 2021 Aug 9;21(1):770
pubmed: 34372789
Clin Infect Dis. 2006 Jan 1;42(1):57-62
pubmed: 16323092
Diabet Med. 2001 Oct;18(10):822-7
pubmed: 11678973
Eur J Clin Microbiol Infect Dis. 2016 Feb;35(2):293-8
pubmed: 26670675
Diabetes Care. 1990 May;13(5):513-21
pubmed: 2351029
Int Wound J. 2017 Dec;14(6):1219-1224
pubmed: 28722354
Med Clin North Am. 2013 Sep;97(5):911-46
pubmed: 23992901
Int J Endocrinol. 2016;2016:8198714
pubmed: 27123004
Diabet Med. 2008 Jun;25(6):700-7
pubmed: 18544108
Clin Infect Dis. 2012 Jun;54(12):e132-73
pubmed: 22619242
Rev Soc Bras Med Trop. 2015 Sep-Oct;48(5):546-54
pubmed: 26516963
Diabetes Care. 2008 Apr;31(4):637-42
pubmed: 18184898
Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1287-1291
pubmed: 30980264
Diabetes Care. 2001 Jan;24(1):78-83
pubmed: 11194246
Diabet Med. 2006 Apr;23(4):341-7
pubmed: 16620261
PLoS One. 2019 May 16;14(5):e0216701
pubmed: 31095593
Diabet Med. 2018 Jan;35(1):78-88
pubmed: 29083500
Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:163-78
pubmed: 22271739
Diabet Med. 2008 Feb;25(2):134-7
pubmed: 18215177
Nurs Times. 2015 Sep 2-15;111(36-37):4
pubmed: 26434180
Wound Repair Regen. 2016 Sep;24(5):923-927
pubmed: 27388112
Clin Infect Dis. 2007 Feb 15;44(4):562-5
pubmed: 17243061
J Diabetes Investig. 2022 Feb;13(2):336-343
pubmed: 34418309
Front Surg. 2021 Apr 30;8:655902
pubmed: 33996886
Diabet Med. 2002 Dec;19(12):1032-4
pubmed: 12647846
J Hosp Med. 2010 Sep;5(7):415-20
pubmed: 20845440
Health Technol Assess. 2006 Apr;10(12):iii-iv, ix-x, 1-221
pubmed: 16595081
Diabetologia. 2007 Jan;50(1):18-25
pubmed: 17093942
Trials. 2021 Aug 3;22(1):517
pubmed: 34344428
Diabetologia. 2010 Oct;53(10):2249-55
pubmed: 20571753
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280
pubmed: 32176444
Diabetologia. 2010 May;53(5):914-23
pubmed: 20146051
Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3276
pubmed: 31958217
Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:45-74
pubmed: 26386266
Clin Infect Dis. 2009 Apr 1;48(7):888-93
pubmed: 19228109
Int J Diabetes Dev Ctries. 2022 Jul;42(3):529-537
pubmed: 34522073